Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Histopathology. 2022 Jan;80(1):98–108. doi: 10.1111/his.14449

Table 1.

Clinico-pathologic features and genetic alterations of Rhabdomyosarcoma subtypes.

RMS Subtype Age (at presentation) Location Morphology Genetic alterations Prognosis
Embryonal RMS Pediatric (0-5) H&N, GU, GYN tract primitive to small blue round cells, scattered rhabdomyoblasts, botryoid pattern Aneuploidy with chromosomal gains and losses; Alterations of the RAS family genes (HRAS, NRAS, KRAS), FGFR4, PIK3CA, NF1 and FBXW7 Favorable
Alveolar RMS Pediatric (10-20) Extremities alveolar pattern, sheets of medium sized cells, scattered giant cells PAX3-FOXO1 gene fusion; PAX7-FOXO1 gene fusion Poor
Spindle cell / sclerosing RMS Infantile, Pediatric and Adults H&N, paratesticular, extremities spindle cells in fascicles; sclerosing ‘pseudovascular’ pattern VGLL2 / NCOA2 gene fusions (infantile) ; MYOD1 gene mutation Infantile – favorable; MYOD1 mutant - poor
Pleomorphic RMS Adults Extremities pleomorphic rhabdomyoblasts Complex genetic alterations Poor